Will magnetic resonance imaging (MRI)-based contrast agents for molecular receptor imaging make their way into the clinic?

被引:7
作者
Glunde, Kristine [1 ]
Bhujwalla, Zaver M. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, JHU ICMIC Program, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA
关键词
D O I
10.1111/j.1582-4934.2008.00248.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:187 / 188
页数:2
相关论文
共 9 条
[1]  
Artemov D, 2003, CANCER RES, V63, P2723
[2]   Imaging of tumor angiogenesis: Current approaches and future prospects [J].
Daldrup-Link, Heike E. ;
Simon, Gerhard H. ;
Brasch, Robert C. .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (21) :2661-2672
[3]  
Jin ZH, 2006, MOL IMAGING, V5, P188
[4]   New directions in ultrasound: microbubble contrast [J].
Stewart, VR ;
Sidhu, PS .
BRITISH JOURNAL OF RADIOLOGY, 2006, 79 (939) :188-194
[5]  
Theuer Charles P, 2004, Biotechnol Annu Rev, V10, P265
[6]   In vivo detection of c-Met expression in a rat C6 glioma model [J].
Towner, R. A. ;
Smith, N. ;
Doblas, S. ;
Tesiram, Y. ;
Garteiser, P. ;
Saunders, D. ;
Cranford, R. ;
Silasi-Mansat, R. ;
Herlea, O. ;
Ivanciu, L. ;
Wu, D. ;
Lupu, F. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2008, 12 (01) :174-186
[7]   Radiolabeled peptides in oncology - Role in diagnosis and treatment [J].
Weiner, RE ;
Thakur, ML .
BIODRUGS, 2005, 19 (03) :145-163
[8]  
Weller GER, 2005, CANCER RES, V65, P533
[9]  
Yao Daniel, 2002, Semin Urol Oncol, V20, P211, DOI 10.1053/suro.2002.36250